학술논문
Measured body size and serum estrogen metabolism in postmenopausal women: the Ghana Breast Health Study
Document Type
Report
Author
Geczik, Ashley M.; Falk, Roni T.; Xu, Xia; Ansong, Daniel; Yarney, Joel; Wiafe-Addai, Beatrice; Edusei, Lawrence; Dedey, Florence; Vanderpuye, Verna; Titiloye, Nicholas; Adjei, Ernest; Aitpillah, Francis; Osei-Bonsu, Ernest; Oppong, Joseph; Biritwum, Richard; Nyarko, Kofi; Wiafe, Seth; Awuah, Baffour; Clegg-Lamptey, Joe-Nat; Ahearn, Thomas U.; Figueroa, Jonine; Garcia-Closas, Montserrat; Brinton, Louise A.; Trabert, Britton
Source
Breast Cancer Research. January 26, 2022, Vol. 24 Issue 1
Subject
Language
English
ISSN
1465-5411
Abstract
Author(s): Ashley M. Geczik[sup.1], Roni T. Falk[sup.1], Xia Xu[sup.2], Daniel Ansong[sup.3], Joel Yarney[sup.4], Beatrice Wiafe-Addai[sup.5], Lawrence Edusei[sup.4], Florence Dedey[sup.4], Verna Vanderpuye[sup.4], Nicholas Titiloye[sup.6], Ernest Adjei[sup.6], Francis Aitpillah[sup.6], Ernest Osei-Bonsu[sup.6], Joseph [...]
Background Several anthropometric measures have been associated with hormone-related cancers, and it has been shown that estrogen metabolism in postmenopausal women plays an important role in these relationships. However, little is known about circulating estrogen levels in African women, and the relevance to breast cancer or breast cancer risk factors. To shed further light on the relationship of anthropometric factors and estrogen levels in African women, we examined whether measured body mass index (BMI), waist-to-hip ratio (WHR), height, and self-reported body size were associated with serum estrogens/estrogen metabolites in a cross-sectional analysis among postmenopausal population-based controls of the Ghana Breast Health Study. Methods Fifteen estrogens/estrogen metabolites were quantified using liquid chromatography-tandem mass spectrometry in serum samples collected from postmenopausal female controls enrolled in the Ghana Breast Health Study, a population-based case-control study conducted in Accra and Kumasi. Geometric means (GMs) of estrogens/estrogen metabolites were estimated using linear regression, adjusting for potential confounders. Results Measured BMI ([greater than or equai to] 30 vs. 18.5-24.9 kg/m.sup.2) was positively associated with parent estrogens (multivariable adjusted GM for unconjugated estrone: 78.90 (66.57-93.53) vs. 50.89 (43.47-59.59), p-value < 0.0001; and unconjugated estradiol: 27.83 (21.47-36.07) vs. 13.26 (10.37-16.95), p-value < 0.0001). Independent of unconjugated estradiol, measured BMI was associated with lower levels of 2-pathway metabolites and higher levels of 16-ketoestradriol. Similar patterns of association were found with WHR; however, the associations were not entirely independent of BMI. Height was not associated with postmenopausal estrogens/estrogen metabolite levels in African women. Conclusions We observed strong associations between measured BMI and parent estrogens and estrogen metabolite patterns that largely mirrored relations that have previously been associated with higher breast cancer risk in postmenopausal White women. The consistency of the BMI-estrogen metabolism associations in our study with those previously noted among White women suggests that estrogens likely explain part of the BMI-postmenopausal breast cancer risk in both groups. These findings merit evaluation in Black women, including prospective studies. Keywords: Measured body mass index, Height, Waist-to-hip ratio, Estrogen metabolism, Postmenopausal Black women
Background Several anthropometric measures have been associated with hormone-related cancers, and it has been shown that estrogen metabolism in postmenopausal women plays an important role in these relationships. However, little is known about circulating estrogen levels in African women, and the relevance to breast cancer or breast cancer risk factors. To shed further light on the relationship of anthropometric factors and estrogen levels in African women, we examined whether measured body mass index (BMI), waist-to-hip ratio (WHR), height, and self-reported body size were associated with serum estrogens/estrogen metabolites in a cross-sectional analysis among postmenopausal population-based controls of the Ghana Breast Health Study. Methods Fifteen estrogens/estrogen metabolites were quantified using liquid chromatography-tandem mass spectrometry in serum samples collected from postmenopausal female controls enrolled in the Ghana Breast Health Study, a population-based case-control study conducted in Accra and Kumasi. Geometric means (GMs) of estrogens/estrogen metabolites were estimated using linear regression, adjusting for potential confounders. Results Measured BMI ([greater than or equai to] 30 vs. 18.5-24.9 kg/m.sup.2) was positively associated with parent estrogens (multivariable adjusted GM for unconjugated estrone: 78.90 (66.57-93.53) vs. 50.89 (43.47-59.59), p-value < 0.0001; and unconjugated estradiol: 27.83 (21.47-36.07) vs. 13.26 (10.37-16.95), p-value < 0.0001). Independent of unconjugated estradiol, measured BMI was associated with lower levels of 2-pathway metabolites and higher levels of 16-ketoestradriol. Similar patterns of association were found with WHR; however, the associations were not entirely independent of BMI. Height was not associated with postmenopausal estrogens/estrogen metabolite levels in African women. Conclusions We observed strong associations between measured BMI and parent estrogens and estrogen metabolite patterns that largely mirrored relations that have previously been associated with higher breast cancer risk in postmenopausal White women. The consistency of the BMI-estrogen metabolism associations in our study with those previously noted among White women suggests that estrogens likely explain part of the BMI-postmenopausal breast cancer risk in both groups. These findings merit evaluation in Black women, including prospective studies. Keywords: Measured body mass index, Height, Waist-to-hip ratio, Estrogen metabolism, Postmenopausal Black women